Azimuth Capital Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Azimuth Capital Investment Management's PFE Position: Q1 2026 in Review
Azimuth Capital Investment Management increased its Pfizer (PFE) stake by 5.5% in Q1 2026, buying an estimated $556K and bringing the position to 401,847 shares worth $11.3M. The position accounts for 0.42% of the portfolio, ranked #82.
Azimuth Capital Investment Management first reported a position in PFE in Q2 2022 and has held it in 16 quarters since. The position peaked at $28.3M in Q2 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Azimuth Capital Investment Management held 401,847 shares of Pfizer worth $11.3M as of Q1 2026.
- Azimuth Capital Investment Management bought 20,888 Pfizer shares in Q1 2026, an estimated $556K.
- Pfizer made up 0.42% of Azimuth Capital Investment Management's portfolio in Q1 2026, its #82 holding.
- Azimuth Capital Investment Management first reported a position in Pfizer in Q2 2022 and has held it in 16 quarters since.
- Azimuth Capital Investment Management's Pfizer position peaked at $28.3M in Q2 2022.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Azimuth Capital Investment Management's 13F filing for Q1 2026, filed 12 May 2026.